Tom is the founder and CEO of Arcturus Engineering, Inc. a biotechnology company developing revolutionary instrumentation for understanding the molecular basis of disease. Prior to founding Arcturus, Tom was VP of research at Spectra-Physics Laser Diode Systems and Biometric Imaging, Inc.. He is also currently a managing director of Incubic, an early stage investment group.

Tom is recognized internationally as a pioneer in the commercial development of biomedical instrumentation and laser technology. His research has resulted in over fifty scientific articles, several dozen commercial products, as well as many industrial awards for design innovation. He is an inventor on 46 issued US patents. He has been recognized for his contributions in the fields of quantum electronics and biotechnology by his election to the status of Fellow by two leading international scientific societies: the Optical Society of America and the American Association for the Advancement of Science.  

Ken founded Clontech Laboratories, Inc. in 1984 and served as its CEO until the company merged with Becton Dickinson in August 1999. Clontech is currently has 400 people ( 65 PhD scientists). It produces and markets products to academic and pharmaceutical labs in the US and 30 other countries. In 1990, Clontech was selected in 1990 by Inc Magazine as one of the 500 fastest-growing, privately-held companies in the US and was selected by the San Francisco and San Jose Business Journals in 1994, 1995, 1998 and 1999 as one of the 100 fastest-growing private companies in the Bay Area.

Ken is currently the Chairman of Kenson Ventures LLC, an investment company specializing in early stage biotechnology companies. He currently serves on the Board and/or as Advisory Board Member for 12 biotech companies.

Ken's numerous honors and positions include: Member of a 3-member Biotech Study Group for the Innovation & Technology Commission for the Hong Kong Government (September -December,2000); Member of Advisory Board, Developmental Center for Biotechnology (DCB), Taiwan; Member of Advisory Board, Biochip Center, Tsing Hua University, Beijing; Planning Advisory Board, Graduate Program at University of the Pacific; Advisory Board of Associates, Whitehead Biomedical Institute at MIT; Board Member, Analytical and Life Sciences Systems Association (US); Hall of Fame Alumnus, San Francisco State University; Member of Committee of 100, a group of prominent Chinese-Americans in the US; Advisory Board Member of Medical Biotechnology, Academia Sinica, Taiwan; Scientific Advisory Board Member, San Francisco State University; and Chairman, long-range Planning Committee, Society for Chinese Bioscientists in America (SCBA) (currently President - Biopharmaceutical Division, SCBA; and Board member and President (1989) of Asian American Manufacturers" Association (AAMA) in Silicon Valley.

Ken received his doctorate degree in Molecular Biology and Microbiology from Indiana University and his Bachelors of Arts degree in Biology (concentration : Genetics) at San Francisco State University.  

Hugh co-founded Oratec Interventions (OTEC: NASDAQ) and has served as a director since its inception. From April 1995 until July 1997, he served as Chief Executive Officer, President and Chief Financial Officer, and in June 1997 he became Executive Vice President and Chief Technical Officer. Oratec develops and markets innovative medical devices that use controlled thermal energy to treat spine and joint disorders.

In March 1994, Hugh co-founded ZoMed International (now RITA Medial Systems; RITA: NASDAQ), a radiofrequency ablation company. In 1992, Hugh co-founded VIDAMed, (VIDA: NASDAQ) a urology company, and in 1987, he co-founded Danforth Biomedical, (now ACT Medical) a medical device development company. From May 1998 to May 1989, he served as Vice President and General Manager of EP Technologies, (now a Boston Scientific Company), a cardiac electrode company, which was acquired by Boston Scientific. Mr. Sharkey has raised over $50M in private financings for start-up companies, and is listed as an inventor on over 70 patents for medical devices.